Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A First-in-Human Single and Multiple Ascending Dose Study of MT-201 — Stella

Home/Healthy Volunteer/A First-in-Human Single and Multiple Ascending Dose Study of MT-201

View on ClinicalTrials.gov

Recruiting

Back to Healthy Volunteer trials

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Mirador Clinical Department, San Diego, California 92121, San Diego, California

Key details

Phase

Early testing

Sponsor

Mirador Therapeutics, Inc.

Enrollment target

~72 participants

Started

October 2025

Primary completion

November 2026

Age range

19 Years – 55 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.